Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics.

Diabetes research and clinical practice - 1 Nov 2016

Dhawan Dipali, Padh Harish

Abstract excerpt

Sulfonylureas are widely used to treat type 2 diabetes, with considerable inter-individual variation in the hypoglycaemic response to sulfonylureas. Genetic variants in the gene encoding for transcription factor-7-like 2 (TCF7L2) have been associated with type 2 diabetes. This study aimed to study the effect of variations in TCF7L2 on therapeutic response to sulfonylureas in Type 2 diabetes mellitus patients. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Blood Glucose
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycated Hemoglobin

Share to Multiplex Polymerase Chain Reaction

Share to Sulfonylurea Compounds

Share to Transcription Factor 7-Like 2 Protein

Source

Identifiers

PMID: 27639123
DOI: 10.1016/j.diabres.2016.08.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics.PMID 27639123Read ↗

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.Semantic proximity Read ↗

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetesSemantic proximity Read ↗

KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.Semantic proximity Read ↗

TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes.Semantic proximity Read ↗

TCF7L2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus, A Pilot StudySemantic proximity Read ↗

The Role of TCF7L2 in Type 2 Diabetes.Semantic proximity Read ↗

Genetic Variants Identified from GWAS for Predisposition to Type 2 Diabetes Predict Sulfonylurea Drug Response.Semantic proximity Read ↗

Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis.Semantic proximity Read ↗

Association between<i>TCF7L2</i>Genotype and Glycemic Control in Diabetic Patients Treated with GliclazideSemantic proximity Read ↗

Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group.Semantic proximity Read ↗

Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.Semantic proximity Read ↗

The association between gene polymorphism of TCF7L2 and type 2 diabetes in Chinese Han population: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.